Skip to main content
letter
. 2004 Oct 26;91(10):1800–1807. doi: 10.1038/sj.bjc.6602221

Table 2. Comparison of chemosensitivity in the MDA-MB-435S-F cell line and its doxorubicin selected variants.

  IC50 (ng ml−1)
Drug MDA-MB- 435S-F MDA-MB-435S- F/Adr-10p Fold resistance of MDA-MB-435S-F/Adr-10p MDA-MB-435S- F/Adr-10p10p Fold resistance of MDA-MB-435S-F/Adr-10p10p
Doxorubicin 271±3 316±15 1.16 381±11.54** 1.40
Paclitaxel 28.3±1.52 20.3±2.1* 0.71 17.6±0.2* 0.62
Carboplatin 41 300±1500 37 600±1150 0.91 24 600±1520* 0.59
Docetaxel 3.33±0.37 3.76±0.20 1.12 4.76±0.152* 1.42
VP-16 1844±77 2663±148** 1.44 3785±79** 2.05
5-Fluorouracil 7430±680 3360±400* 0.45 3430±50* 0.46
Vincristine 12.9±1.3 6.9±0.69** 0.53 32.1±2.5** 1.61
a

The IC50 values are the mean of a minimum of three repeat experiments.

*

P<0.05, Student's t-test.

**

P<0.005, Student's t-test.